Natural Science Foundation of Guizhou Province,China,No.397.
BACKGROUND Allogeneic hematopoietic stem cell transplantation(Allo-HSCT)is currently the only viable method of curing patients with acute myeloid leukaemia.In 30%to 50%of patients,donors and recipients have some level...
We reported a case of severe anemia in a patient with end-stage kidney disease (ESKD) on dialysis. The anemia developed when the patient is switched from hemodialysis (HD) to peritoneal dialysis (PD) when the intra-ve...
抗EPO抗体相关纯红细胞再生障碍性贫血是一种应用重组人促红细胞生成素(recombinant human erythropoietin,rHuEPO)而引起的纯红细胞再生障碍性贫血(pure red cell aplasia,PRCA),临床上比较少见,其主要特点为rHuEPO治疗无效,呈进行性贫...
This work was supported by the grants from the National Natural Science Foundation of China (Nos. 81372637 and 81502423), the National Key Technology R&D Program of China (No. 2014BAI0 9B03), the Key Projects in Shanghai Science & Technology Pillar Program for Biomedicine (No. 14431904700) and Shanghai Pujiang Program (No. 16PJ1405300).
Idiopathic acquired pure red cell aplasia (PRCA) is a rare, autoimmune-related disease. This study aimed to describe the previously unidentified DNA alterations associated with PRCA. Here, next generation sequencing...